BioSpace News Archive

Oncotelic Therapeutics, Inc. and COVID-19 and Golden Mountain Partners, ( “ GMP ” ) announced that they are forming a joint venture ( “JV” ) to advance clinical development of Oncotelic’s pharmaceutical pipeline and build out of manufacturing facilities for the commercial launch of Oncotelic’s drug candidates.

VBL Therapeutics announced financial results for the second quarter ended June 30, 2021, and provided a corporate update.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that it has received U.S. Food and Drug Administration approval for its ADMA BioCenters plasma collection facility located in Maryville, Tennessee.

FibroGen, Inc. (NASDAQ: FGEN) announced the retirement of Pat Cotroneo, Chief Financial Officer, and the appointment of Juan Graham in that role.

The U.S. Food and Drug Administration (FDA) has approved an expanded label for Eli Lilly and Company’s (NYSE: LLY) rapid-acting insulin, Lyumjev ®

The occurrence of psoriatic arthritis can place an extremely negative toll on the overall health of individuals.

Increase in number of patients living with various dental and related health issues is stimulating the sales avenues in the global needle recapping market.

The popularity of various formulations in the fixed dose combination drugs market stems largely from the fact that they hold great promise in improving adherence to long-term multi-drug therapies.

Biophytis SA announces the recommendation by the Data Monitoring Committee to continue patient recruitment into part 2 of the COVA study with the protocol unmodified after review of safety data.

Occlutech Holding AG announces the conditional U.S. Food and Drug Administration approval of its Investigational Device Exemption application to conduct a pivotal study, OCCLUFLEX, comparing Patent Foramen Ovale closure by Occlutech’s Flex II PFO Occluder to the standard of care for PFO occlusion in patients with cryptogenic stroke.